Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 1 (2004), Issue 2 (November)

1. Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen.
   Am J Epidemiol, 160(10): 977-84. [Abstract] [Full-text]
2. Behavioral and anatomical effects of quinolinic acid in the striatum of the hemiparkinsonian rat.
   Synapse, 55(1): 26-36. [Abstract] [Full-text]
3. Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease.
   Mov Disord, 19(12): 1438-45. [Abstract] [Full-text]
4. Brain parenchyma sonography detects preclinical parkinsonism.
   Mov Disord, 19(12): 1445-9. [Abstract] [Full-text]
5. Neuronal activity in the globus pallidus of multiple system atrophy patients.
   Mov Disord, 19(12): 1485-92. [Abstract] [Full-text]
6. Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease.
   Mov Disord, 19(12): 1463-9. [Abstract] [Full-text]
7. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
   Mov Disord, 19(12): 1511-5. [Abstract] [Full-text]
8. Nurr1 mutational screen in Parkinson's disease.
   Mov Disord, 19(12): 1503-5. [Abstract] [Full-text]
9. Parkinson's disease home diary: further validation and implications for clinical trials.
   Mov Disord, 19(12): 1409-13. [Abstract] [Full-text]
10. Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease.
    Mov Disord, 19(12): 1403-8. [Abstract] [Full-text]
11. Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tape.
    Mov Disord, 19(12): 1453-6. [Abstract] [Full-text]
12. Occupations and Parkinson's disease: a multi-center case-control study in South Korea.
    Neurotoxicology, 26(1): 99-105. [Abstract] [Full-text]
13. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry.
    Neuroscientist, 10(6): 525-37. [Abstract] [Full-text]
14. Analysis of MDR1 haplotypes in Parkinson's disease in a white population.
    Neurosci Lett, 372(3): 240-4. [Abstract] [Full-text]
15. Genetic association study of PINK1 coding polymorphisms in Parkinson's disease.
    Neurosci Lett, 372(3): 226-9. [Abstract] [Full-text]
16. Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation.
    Parkinsonism Relat Disord, 10(8): 507-10. [Abstract] [Full-text]
17. Dynamic estimation of hand position is abnormal in Parkinson's disease.
    Parkinsonism Relat Disord, 10(8): 501-6. [Abstract] [Full-text]
18. Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson's disease patients in Singapore.
    Parkinsonism Relat Disord, 10(8): 493-9. [Abstract] [Full-text]
19. Somatic symptom progression in idiopathic Parkinson's disease.
    Parkinsonism Relat Disord, 10(8): 487-92. [Abstract] [Full-text]
20. Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy.
    Parkinsonism Relat Disord, 10(8): 481-5. [Abstract] [Full-text]
21. Deep brain stimulation of the subthalamic nucleus reduces antiparkinsonian medication costs.
    Parkinsonism Relat Disord, 10(8): 475-9. [Abstract] [Full-text]
22. The homozygote AA genotype of the alpha1-antichymotrypsin gene may confer protection against early-onset Parkinson's disease in women.
    Parkinsonism Relat Disord, 10(8): 469-73. [Abstract] [Full-text]
23. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.
    Neuron, 44(4): 595-600. [Abstract] [Full-text]
24. Protein kinases linked to the pathogenesis of Parkinson's disease.
    Neuron, 44(4): 575-7. [Abstract] [Full-text]
25. The neuropsychiatry of Parkinson's disease and related disorders.
    Psychiatr Clin North Am, 27(4): 801-25. [Abstract] [Full-text]
26. Olfactory function distinguishes vascular parkinsonism from Parkinson's disease.
    J Neurol Neurosurg Psychiatry, 75(12): 1749-52. [Abstract] [Full-text]
27. Repetitive training of compensatory steps: a therapeutic approach for postural instability in Parkinson's disease.
    J Neurol Neurosurg Psychiatry, 75(12): 1682-7. [Abstract] [Full-text]
28. Greater syntactic impairments in native language in bilingual Parkinsonian patients.
    J Neurol Neurosurg Psychiatry, 75(12): 1678-81. [Abstract] [Full-text]
29. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.
    J Neurol Neurosurg Psychiatry, 75(12): 1672-7. [Abstract] [Full-text]
30. Surgical treatment for Parkinson's disease.
    Lancet Neurol, 3(12): 719-28. [Abstract] [Full-text]
31. Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study.
    Drug Alcohol Depend, 76(3): 305-10. [Abstract] [Full-text]
32. Alpha-synuclein structures from fluorescence energy-transfer kinetics: implications for the role of the protein in Parkinson's disease.
    Proc Natl Acad Sci U S A, 101(47): 16466-71. [Abstract] [Full-text]
33. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
    Brain, 127: 2732-46. [Abstract] [Full-text]
34. Electron microscopy of tissue adherent to explanted electrodes in dystonia and Parkinson's disease.
    Brain, 127: 2755-63. [Abstract] [Full-text]
35. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.
    Brain, 127: 2747-54. [Abstract] [Full-text]
36. Health related quality of life in patients with Parkinson's disease two years following posteroventral pallidotomy.
    Acta Neurochir (Wien), 146(12): 1293-9; discussion 1299. [Abstract] [Full-text]
37. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Trends Cell Biol, 14(12): 703-11. [Abstract] [Full-text]
38. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes.
    J Neural Transm, 111(12): 1543-73. [Abstract] [Full-text]
39. Changes in distal muscle timing may contribute to slowness during sit to stand in Parkinsons disease.
    Clin Biomech (Bristol, Avon), 20(1): 112-7. [Abstract] [Full-text]
40. Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease.
    Neurochem Int, 46(1): 11-8. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.